NCT04595786View on ClinicalTrials.gov

The Safety of Intravenous Tranexamic Acid in Patients Undergoing Supratentorial Meningiomas Resection

NACompletedINTERVENTIONAL
Enrollment

228

Participants

Timeline

Start Date

October 30, 2020

Primary Completion Date

January 11, 2024

Study Completion Date

July 11, 2024

Conditions
SeizuresMeningioma
Interventions
DRUG

Tranexamic acid

20mg/kg TXA was prepared in a 50ml syringe for intravenous pump

DRUG

0.9% saline

0.9% saline was prepared in a 50ml syringe for intravenous pump

Trial Locations (1)

100070

Beijing Tiantan Hospital, Beijing

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER

NCT04595786 - The Safety of Intravenous Tranexamic Acid in Patients Undergoing Supratentorial Meningiomas Resection | Biotech Hunter | Biotech Hunter